Company profile: Moleculo
1.1 - Company Overview
Company description
- Provider of technologies for generating long reads for genome analysis tools, offering a novel DNA sequencing method that delivers long, accurate reads and improves the efficiency and accuracy of many existing DNA sequencing applications.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Moleculo
Brahms
HQ: Germany
Website
- Description: Provider of biomarker-based diagnostic test procedures and automated immunoanalyzers (KRYPTOR) using TRACE technology to improve diagnosis and treatment of life-threatening illnesses. Offerings include biomarkers for prenatal screening, oncology and thyroid disease management; sFlt-1/PlGF for preeclampsia risk; CgA II for neuroendocrine tumor monitoring; TRAK human for Graves’ disease; and Copeptin proAVP for water balance and acute myocardial infarction.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Brahms company profile →
Codexis
HQ: United States
Website
- Description: Provider of enzyme discovery and RNA manufacturing solutions, offering the CodeEvolver platform to discover, develop, and enhance novel enzymes and proteins; ECO Synthesis technology for scaled enzymatic production of RNAi therapeutics; custom enzymes to improve small molecule pharmaceutical manufacturing; RNA ligase screening and optimization; and high-yield RNA manufacturing services.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Codexis company profile →
Genesis Genetics
HQ: United States
Website
- Description: Provider of preimplantation genetic diagnosis (PGD) and preimplantation genetic screening (PGS), delivering expert laboratory services to respected IVF centers across the country and worldwide for pre-implantation testing of embryos for inherited genetic abnormalities.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Genesis Genetics company profile →
AccuraGen
HQ: United States
Website
- Description: Provider of cancer early detection solutions: a liquid biopsy platform using unique biochemistry and machine learning to extract cancer signals in plasma for treatment guidance, minimal residue disease detection, and early screening; and CLAmp-seq technology to detect multiple cancer signals in blood and analyze them with machine learning for multi-cancer early detection tests.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AccuraGen company profile →
AnimalBiome
HQ: United States
Website
- Description: Provider of microbiome-focused pet health solutions for dogs and cats, including gut health test kits for stool-based microbiome analysis, gut restore supplements with healthy bacteria, gut maintenance products with prebiotics and probiotics, oral health products with prebiotic action, a State of the Gut report with dietary and exercise recommendations, and microbiome research partnerships.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full AnimalBiome company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Moleculo
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Moleculo
2.2 - Growth funds investing in similar companies to Moleculo
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Moleculo
4.2 - Public trading comparable groups for Moleculo
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →